Headlands Technologies’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,341
| Closed | -$222K | – | 1147 |
|
|
2025
Q1 | $222K | Sell |
13,341
-34,916
| -72% | -$580K | 0.03% | 439 |
|
|
2024
Q4 | $886K | Buy |
48,257
+3,619
| +8% | +$66.4K | 0.09% | 234 |
|
|
2024
Q3 | $687K | Sell |
44,638
-12,571
| -22% | -$193K | 0.08% | 271 |
|
|
2024
Q2 | $930K | Buy |
57,209
+54,608
| +2,100% | +$887K | 0.1% | 180 |
|
|
2024
Q1 | $48.1K | Buy |
+2,601
| New | +$48.1K | 0.01% | 732 |
|
|
2023
Q3 | – | Sell |
-5,562
| Closed | -$133K | – | 890 |
|
|
2023
Q2 | $133K | Buy |
+5,562
| New | +$133K | 0.04% | 342 |
|